Intrinsic damage to the major white matter tracts in patients with different clinical phenotypes of multiple sclerosis: A voxelwise diffusion-tensor MR study

Radiology

Volumn 260, Issue 2, 2011, Pages 541-550

  Preziosa, Paolo ^a   Rocca, Maria A ^a   Mesaros, Sarlota ^b   Pagani, Elisabetta ^a   Stosic Opincal, Tatjana ^b   Kacar, Katarina ^a   Absinta, Martina ^a   Caputo, Domenico ^c   Drulovic, Jelena ^b   Comi, Giancarlo ^a   Filippi, Massimo ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b UNIVERSITY OF BELGRADE   (Serbia)

^c IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN DAMAGE; BRAIN FUNCTION; CONTROLLED STUDY; DIFFUSION TENSOR IMAGING; ELECTROENCEPHALOGRAM; FEMALE; FRACTIONAL ANISOTROPY; GENETIC HETEROGENEITY; HUMAN; IMAGE ANALYSIS; IMAGE DISPLAY; IMAGE PROCESSING; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NEUROIMAGING; PHENOTYPE; PRIORITY JOURNAL; WHITE MATTER;

ADULT; AGED; ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; DIFFUSION MAGNETIC RESONANCE IMAGING; DISABILITY EVALUATION; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LINEAR MODELS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NERVE FIBERS, MYELINATED; PHENOTYPE;

EID: 79960696415     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.11110315     Document Type: Article

References (32)

1. Lassmann H, Brück W, Lucchinetti CF. The immunopathology of multiple sclerosis: an overview. Brain Pathol 2007;17(2):210-218. (Pubitemid 46466140)
2. Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey - National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 1996;46(4):907-911.
3. Barkhof F, Calabresi PA, Miller DH, Reingold SC. Imaging outcomes for neuroprotection and repair in multiple sclerosis trials. Nat Rev Neurol 2009;5(5):256-266.
4. Barkhof F. The clinico-radiological paradox in multiple sclerosis revisited. Curr Opin Neurol 2002;15(3):239-245. (Pubitemid 34596884)
5. Pagani E, Filippi M, Rocca MA, Horsfield MA. A method for obtaining tract-specific diffusion tensor MRI measurements in the presence of disease: application to patients with clinically isolated syndromes suggestive of multiple sclerosis. Neuroimage 2005;26(1): 258-265. (Pubitemid 40602905)
6. Rocca MA, Valsasina P, Ceccarelli A, et al. Structural and functional MRI correlates of Stroop control in benign MS. Hum Brain Mapp 2009;30(1):276-290.
7. Wilson M, Tench CR, Morgan PS, Blumhardt LD. Pyramidal tract mapping by diffusion tensor magnetic resonance imaging in multiple sclerosis: improving correlations with disability. J Neurol Neurosurg Psychiatry 2003;74(2):203-207. (Pubitemid 36160681)
8. Mesaros S, Rocca MA, Riccitelli G, et al. Corpus callosum damage and cognitive dysfunction in benign MS. Hum Brain Mapp 2009;30(8):2656-2666.
9. Raz E, Cercignani M, Sbardella E, et al. Clinically isolated syndrome suggestive of multiple sclerosis: voxelwise regional investigation of white and gray matter. Radiology 2010;254(1):227-234.
10. Lin F, Yu C, Jiang T, Li K, Chan P. Diffusion tensor tractography-based group mapping of the pyramidal tract in relapsing-remitting multiple sclerosis patients. AJNR Am J Neuroradiol 2007;28(2):278-282. (Pubitemid 46281045)
11. Pierpaoli C, Barnett A, Pajevic S, et al. Water diffusion changes in Wallerian degeneration and their dependence on white matter architecture. Neuroimage 2001;13(6 Pt 1): 1174-1185. (Pubitemid 32553548)
12. Song SK, Sun SW, Ju WK, Lin SJ, Cross AH, Neufeld AH. Diffusion tensor imaging detects and differentiates axon and myelin degeneration in mouse optic nerve after retinal ischemia. Neuroimage 2003;20(3): 1714-1722. (Pubitemid 37468277)
13. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33(11): 1444-1452. (Pubitemid 14237132)
14. Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011;69(2):292-302.
15. Pittock SJ, McClelland RL, Mayr WT, et al. Clinical implications of benign multiple sclerosis: a 20-year population-based follow-up study. Ann Neurol 2004;56(2):303-306. (Pubitemid 39037929)
16. Basser PJ, Pierpaoli C. Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI. J Magn Reson B 1996;111(3):209-219. (Pubitemid 126758682)
17. Rohde GK, Aldroubi A, Dawant BM. The adaptive bases algorithm for intensity-based nonrigid image registration. IEEE Trans Med Imaging 2003;22(11):1470-1479.
18. Xu D, Mori S, Solaiyappan M, van Zijl PC, Davatzikos C. A framework for callosal fiber distribution analysis. Neuroimage 2002; 17(3):1131-1143. (Pubitemid 35333836)
19. Gallo A, Rovaris M, Riva R, et al. Diffusion-tensor magnetic resonance imaging detects normal-appearing white matter damage unrelated to short-term disease activity in patients at the earliest clinical stage of multiple sclerosis. Arch Neurol 2005;62(5):803-808. (Pubitemid 40656097)
20. Henry RG, Shieh M, Amirbekian B, Chung S, Okuda DT, Pelletier D. Connecting white matter injury and thalamic atrophy in clinically isolated syndromes. J Neurol Sci 2009; 282(1-2):61-66.
21. Raz E, Cercignani M, Sbardella E, et al. Grayand white-matter changes 1 year after first clinical episode of multiple sclerosis: MR imaging. Radiology 2010;257(2):448-454.
22. Miller D, Barkhof F, Montalban X, Thompson A, Filippi M. Clinically isolated syndromes suggestive of multiple sclerosis. I. Natural history, pathogenesis, diagnosis, and prognosis. Lancet Neurol 2005;4(5):281-288.
23. Ceccarelli A, Rocca MA, Pagani E, et al. A voxel-based morphometry study of grey matter loss in MS patients with different clinical phenotypes. Neuroimage 2008;42(1): 315-322.
24. Mesaros S, Rovaris M, Pagani E, et al. A magnetic resonance imaging voxel-based morphometry study of regional gray matter atrophy in patients with benign multiple sclerosis. Arch Neurol 2008;65(9):1223-1230.
25. Alcázar A, Regidor I, Masjuan J, Salinas M, Alvarez-Cermeño JC. Axonal damage induced by cerebrospinal fluid from patients with relapsing-remitting multiple sclerosis. J Neuroimmunol 2000;104(1):58-67. (Pubitemid 30100538)
26. Geurts JJ, Wolswijk G, Bö L, et al. Altered expression patterns of group I and II metabotropic glutamate receptors in multiple sclerosis . Brain 2003;126(Pt 8):1755-1766. (Pubitemid 36917335)
27. Kutzelnigg A, Faber-Rod JC, Bauer J, et al. Widespread demyelination in the cerebellar cortex in multiple sclerosis. Brain Pathol 2007;17(1):38-44.
28. Rovaris M, Bozzali M, Santuccio G, et al. In vivo assessment of the brain and cervical cord pathology of patients with primary progressive multiple sclerosis. Brain 2001; 124(Pt 12):2540-2549.
29. Vrenken H, Seewann A, Knol DL, Polman CH, Barkhof F, Geurts JJ. Diffusely abnormal white matter in progressive multiple sclerosis: in vivo quantitative MR imaging characterization and comparison between disease types. AJNR Am J Neuroradiol 2010;31(3): 541-548.
30. Kutzelnigg A, Lucchinetti CF, Stadelmann C, et al. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 2005;128(Pt 11):2705-2712. (Pubitemid 41552953)
31. Revesz T, Kidd D, Thompson AJ, Barnard RO, McDonald WI. A comparison of the pathology of primary and secondary progressive multiple sclerosis. Brain 1994;117(Pt 4):759-765. (Pubitemid 24281838)
32. Bramow S, Frischer JM, Lassmann H, et al. Demyelination versus remyelination in progressive multiple sclerosis. Brain 2010; 133(10):2983-2998.